SCHEMBL691980

SCHEMBL691980

C/C=C(/C(N)=O)c1cccc(Nc2cc(Nc3ccc(Oc4ccccc4)cc3)ncn2)n1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 8/20 0.48
ERBB3 P21860 6/20 0.48
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SCN9A Q15858 3/20 0.44
ABL1 P00519 3/20 0.43
BCR P11274 3/20 0.43
CDK4 P11802 1/20 0.40
BTK Q06187 1/20 0.40
GRM5 P41594 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
ERBB2 P04626 1/20 0.39
KDR P35968 1/20 0.39
TNNI3K Q59H18 1/20 0.39
SCN5A Q14524 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL691983 1.00 EGFR (0.48) EGFRERBB3MEN1KMT2ANPC1
SCHEMBL691982 0.80 MTNR1A (0.51) EGFRERBB3MEN1KMT2ANPC1
SCHEMBL12262446 0.78 SCN9A (0.64) EGFRERBB3MEN1KMT2ANPC1
SCHEMBL12262542 0.78 MEN1 (0.57) EGFRERBB3MEN1KMT2ANPC1
SCHEMBL691981 0.77 EGFR (0.42) EGFRERBB3MEN1KMT2ANPC1
SCHEMBL12282836 0.77 EGFR (0.53) EGFRERBB3MEN1KMT2ANPC1
SCHEMBL12262344 0.77 EGFR (0.57) EGFRERBB3MEN1KMT2ANPC1
SCHEMBL691695 0.75 MEN1 (0.44) EGFRERBB3MEN1KMT2ANPC1
SCHEMBL3488790 0.74 EGFR (0.51) EGFRERBB3MEN1KMT2ANPC1
SCHEMBL3488793 0.74 EGFR (0.51) EGFRERBB3MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421538-A1 HETEROARYL COMPOUNDS AND USES THEREOF Avila Therapeutics, Inc. (US) 2012-02-29 EP disclosed
WO-2010123870-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2010-10-28 WO disclosed